Serum IL-6: A biomarker in childhood asthma? - 08/06/20
Doi : 10.1016/j.jaci.2020.01.021
Daniel J. Jackson, MD a 
, Leonard B. Bacharier, MD b, Agustin Calatroni, MS c, Michelle A. Gill, MD, PhD d, Jack Hu, MS c, Andrew H. Liu, MD e, Lisa M. Wheatley, MD f, James E. Gern, MD a, Rebecca S. Gruchalla, MD, PhD d, Gurjit K. Khurana Hershey, MD, PhD g, Meyer Kattan, MD h, Carolyn M. Kercsmar, MD g, Haejin Kim, MD i, George T. O’Connor, MD j, Shilpa Patel, MD k, Jacqueline A. Pongracic, MD l, Robert A. Wood, MD m, William W. Busse, MD a
, Leonard B. Bacharier, MD b, Agustin Calatroni, MS c, Michelle A. Gill, MD, PhD d, Jack Hu, MS c, Andrew H. Liu, MD e, Lisa M. Wheatley, MD f, James E. Gern, MD a, Rebecca S. Gruchalla, MD, PhD d, Gurjit K. Khurana Hershey, MD, PhD g, Meyer Kattan, MD h, Carolyn M. Kercsmar, MD g, Haejin Kim, MD i, George T. O’Connor, MD j, Shilpa Patel, MD k, Jacqueline A. Pongracic, MD l, Robert A. Wood, MD m, William W. Busse, MD a a University of Wisconsin School of Medicine and Public Health, Madison, Wis
b Washington University School of Medicine, St Louis, Mo
c Rho Inc, Chapel Hill, NC
d University of Texas Southwestern Medical Center, Dallas, Tex
e Children’s Hospital of Colorado and University of Colorado School of Medicine, Denver, Colo
f National Institute of Allergy and Infectious Diseases, Bethesda, Md
g Cincinnati Children’s Hospital, Cincinnati, Ohio
h Columbia University College of Physicians and Surgeons, New York, NY
i Henry Ford Health System, Detroit, Mich
j Boston University School of Medicine, Boston, Mass
k Children’s National Health System, Washington, DC
l Ann Robert H. Lurie Children’s Hospital of Chicago, Chicago, Ill
m Johns Hopkins University School of Medicine, Baltimore, Md
| This project has been funded in whole or in part with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH) 1UM1AI114271-01. Additional support was provided by the National Center for Research Resources (NCRR), and the National Center for Advancing Translational Sciences (NCATS), NIH (under grant nos. NCRR/NIH UL1TR000451, UL1RR025780, UL1TR000075 Q1 and NCATS/NIH UL1TR000154, UL1TR001082, UL1TR000077-04, UL1TR000040, UL1TR000150, and UL1TR001105). |
|
| Disclosure of potential conflict of interest: D. J. Jackson reports receiving grants from the National Institutes of Health (NIH) and GlaxoSmithKline; personal fees for the Data Safety Monitoring Board from Pfizer; and fees for consulting from Novartis, Sanofi-Regeneron, Vifor Pharma, and Astra Zeneca. L. B. Bacharier reports personal fees from GlaxoSmithKline, Genentech/Novartis, Merck, DBV Technologies, Teva, Boehringer Ingelheim, AstraZeneca, WebMD/Medscape, Sanofi/Regeneron, Vectura, and Circassia. R. A. Wood receives grant support from the NIH, Astellas, Aimmune, DBV, Sanofi, and Regeneron, and royalties from Up To Date. W. W. Busse reports grants from the NIH-National Institute of Allergy and Infectious Diseases, during the conduct of the study; personal fees from AstraZeneca, GlaxoSmithKline, Novartis, Sanofi, Boston Scientific, Regeneron, Arrowhead, resTORbio, Medscape, Gossamer Bio, Genentech, and Elsevier, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2020
American Academy of Allergy, Asthma & Immunology. Tous droits réservés.
Vol 145 - N° 6
P. 1701 - juin 2020 Retour au numéro
Article précédent
- ?IIb-Integrin (CD41) associated with blood eosinophils is a potential biomarker for disease activity in eosinophilic esophagitis
- Mats W. Johansson, Elizabeth M. McKernan, Paul S. Fichtinger, Evelyn L. Angulo, Jennifer L. Bagley, Kristine E. Lee, Michael D. Evans, Luis D. Lomeli, Deane F. Mosher, Shelly M. Cook, Eric A. Gaumnitz, Sameer K. Mathur
- Improving the diagnostic yield for filaggrin: Concealed mutations in the Dutch population
- Frank S. van Leersum, Ivo F. Nagtzaam, Carolien N. van Oosterhoud, Stijn A.I. Ghesquiere, Roel R.H.F.J. Brandts, Antoni Gosty?ski, Peter M. Steijlen, Michel van Geel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?